Lose Weight With GLP-1 Medications.
Start Your Journey With Us Today!
GLP-1 medications in combination with video coaching and lifestyle changes is the most effective program for weight loss.
GLP-1 medications have been covered by
Take These Three Steps Toward the New You!
Complete intake questionnaire
Your doctor will use this information to prepare for your consultation.
Consult with your doctor
Your licensed weight loss doctor will check to determine what treatment is right for you
Enjoy convenient delivery
Your prescription will arrive at your doorstep every month in discrete packaging.
What Are Our Clients Saying?
Trusted Medications.
Caring physicians.
Conveniently delivered to your door.
Experience top-notch telemedicine assistance customized to your specific health needs. Our team of expert clinicians ensures you have ready access to the most effective treatments, prioritizing your well-being.
FREQUENTLY ASKED QUESTIONS
Tell me more about the Ringside Health telemedicine program
What steps do I have to follow to start treatment?
1) Complete the intake questionnaire. Your doctor will use this information to prepare for your consultation, and may order screening tests to determine if treatment is right for you.
2) Have a telehealth consultation with your doctor, who will check what treatment is needed and write a prescription if appropriate.
3) Your prescription will be delivered monthly via mail-order pharmacy.
Will you keep my information private?
Do I need to already have a prescription before I start?
What is the cost of the Ringside Health program?
Can I pay with my HSA or FSA card?
Is this medication safe and is there any reason I should not take it?
When will my medication be delivered?
How do I take my medication?
Is compounded Semaglutide FDA approved?
You can check for drug shortages on the FDA website.
Pharmacies in the CareGLP network comply strictly with all the regulatory standards established by:
- State boards of pharmacy, which regulate all 503A pharmacies
- FDA, which has oversight for the safety of all active pharmaceutical ingredients
- DEA, that oversees the controlled substances sometimes used in compounded preparations
- USP Convention, that issues practice standards ensuring quality and safety of medications and food
- USP General Chapter <795> provides guidelines for the prevention of contamination and potency variance, preparation process, beyond-use dates, and stability for non-sterile compounding
Pharmacies in the CareGLP network run quality assurance and quality control checks for every batch of compounded semaglutide prescribed to patients.
Some of these steps include but are not limited to:
- Reviewing and confirming the Active Pharmaceutical Ingredient (API) Certificate of Analysis for all semaglutide base lots, which are received from FDA-registered manufacturers;
- Storing the verified API frozen and sealed until use;
- Compounding with the API under aseptic processes to produce specific lots (vials);
- Holding the vials of compounded semaglutide in quarantine (representative samples are taken for testing);
- Using independent third-party laboratories to test the potency, sterility and endotoxicity of each lot of compounded semaglutide (among other criteria);
- Reviewing the results of these tests and, if satisfactory, releasing the validated vials from quarantine for dispensing;
- Assigning each compounded lot a unique lot number and BUD (Beyond Use Date), which is added to the container and is tracked electronically;
- Scanning the lot information on the product at the time of dispensing, which ties a particular lot number to the patient’s file.